Amisulpride
- Generic Name
- Amisulpride
- Brand Names
- Barhemsys
- Drug Type
- Small Molecule
- Chemical Formula
- C17H27N3O4S
- CAS Number
- 71675-85-9
- Unique Ingredient Identifier
- 8110R61I4U
- Background
Amisulpride is a benzamide derivative and a dopamine receptor antagonist that selectively works on dopamine D2 and D3 receptors. As an antipsychotic agent, amisulpride alleviates both positive and negative symptoms of schizophrenia, and it exhibits antidepressant properties in patients with psychiatric disorders, dysthymia, and major depression. Amisulpride ...
- Indication
Intravenous amisulpride is indicated in adults for the prevention of postoperative nausea and vomiting, either alone or in combination with an antiemetic of a different class. It is also indicated for the treatment of postoperative nausea and vomiting in patients who have received anti-emetic prophylaxis with an agent of a different class or have not receive...
- Associated Conditions
- Acute Schizophrenia, Chronic Schizophrenia, Negative Symptoms, Post Operative Nausea and Vomiting (PONV)
- Associated Therapies
- -
Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients
- Conditions
- Interventions
- First Posted Date
- 2011-10-07
- Last Posted Date
- 2015-12-09
- Lead Sponsor
- Geha Mental Health Center
- Registration Number
- NCT01448499
- Locations
- 🇮🇱
Geha Mental Health Center, Petach-Tikva, Israel
Bergen Psychosis Project 2 - The Best Intro Study
- Conditions
- Interventions
- First Posted Date
- 2011-10-05
- Last Posted Date
- 2020-06-19
- Lead Sponsor
- Haukeland University Hospital
- Target Recruit Count
- 151
- Registration Number
- NCT01446328
- Locations
- 🇳🇴
Stavanger University Hospital, Stavanger, Norway
🇦🇹Medizinische Universität Innsbruck, Innsbruck, Austria
🇳🇴Haukeland University Hospital, Bergen, Norway
The Effects of Dopamine on Reward Processing
- Conditions
- Interventions
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2018-04-27
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 159
- Registration Number
- NCT01253421
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
- First Posted Date
- 2010-11-23
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 69
- Registration Number
- NCT01246232
- Locations
- 🇬🇧
Imperial College London, London, United Kingdom
🇬🇧University College London, London, United Kingdom
🇬🇧University of Manchester, Manchester, United Kingdom
Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer
- Conditions
- Interventions
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2010-08-20
- Lead Sponsor
- Chonbuk National University Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT01185418
- Locations
- 🇰🇷
Chonbuk national university hospital, Jeonju, Korea, Republic of
Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
- Conditions
- Interventions
- First Posted Date
- 2010-07-13
- Last Posted Date
- 2010-08-03
- Lead Sponsor
- Central Institute of Mental Health, Mannheim
- Target Recruit Count
- 10
- Registration Number
- NCT01160991
- Locations
- 🇩🇪
Central Institute of Mental Health, Mannheim, Germany
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2016-05-26
- Lead Sponsor
- University of Copenhagen
- Target Recruit Count
- 136
- Registration Number
- NCT01154829
- Locations
- 🇩🇰
Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup, Glostrup, Denmark
Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
- Conditions
- Interventions
- First Posted Date
- 2009-08-11
- Last Posted Date
- 2013-01-03
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT00956189
- Locations
- 🇨🇳
Yu-Li Hospital, Yu-Li, Hualien County, Taiwan
🇨🇳Yu-Li Veterans Hospital, Yu-Li, Hualien County, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
Tardive Dyskinesia and Cognitive Function
- Conditions
- Interventions
- First Posted Date
- 2009-06-24
- Last Posted Date
- 2009-06-24
- Lead Sponsor
- Taipei Veterans General Hospital, Taiwan
- Target Recruit Count
- 80
- Registration Number
- NCT00926965
- Locations
- 🇨🇳
Yu-Li Veternas Hospital, Hualien, Taiwan
Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2008-03-18
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 42
- Registration Number
- NCT00628290
- Locations
- 🇩🇪
University of Cologne, Dept. of Psychiatry and Psychotherapy, Cologne, NRW, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.